Novo Nordisk Ships First Weekly Insulin to India, Cutting Injections to 52 a Year but Leaving Daily Options in Place for Many

The product reaches adults with type 1 and type 2 diabetes, yet physicians continue to prescribe daily regimens where weekly dosing falls short.

Novo Nordisk has placed Awiqli on the Indian market as the first insulin formulated for once-weekly use. The launch replaces the prior standard of seven injections per week with a single dose, trimming the annual total from 365 shots to 52 for eligible patients.

Carried by 3 publishers across 3 articles; the full record rides under the article.

Truth Foundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.